LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Sender:
Lactation Information and Discussion <[log in to unmask]>
Date:
Wed, 18 Feb 1998 07:35:59 +0000
Reply-To:
Lactation Information and Discussion <[log in to unmask]>
Subject:
oxybutynin (Ditropan)
MIME-Version:
1.0
Content-Transfer-Encoding:
7bit
Content-Type:
text/plain; charset=us-ascii
From:
newman <[log in to unmask]>
Comments:
cc: "Marla A. Peers" <[log in to unmask]>
Parts/Attachments:
text/plain (7 lines) 
According to Hale, with an oral bioavailability of only 6% and with a
maximum plasma level of <31.7 nanograms/ml, the risk of using this
medication to the baby is almost nil.  On the other hand, the risks of
not breastfeeding... I wouldn't stop breastfeeding.

Jack Newman, MD, FRCPC

ATOM RSS1 RSS2